US Stock MarketDetailed Quotes

ATRA Atara Biotherapeutics

Watchlist
  • 0.694
  • -0.006-0.86%
Close Mar 28 16:00 ET
  • 0.689
  • -0.005-0.71%
Post 18:22 ET
82.84MMarket Cap-265P/E (TTM)

Atara Biotherapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
Total revenue
-52.05%2.14M
-98.14%957K
-83.24%1.23M
212.55%63.57M
-97.07%221K
-16.96%4.46M
1,232.79%51.58M
105.91%7.31M
20.34M
7.55M
Operating revenue
-52.05%2.14M
-98.14%957K
-83.24%1.23M
212.55%63.57M
-97.07%221K
-16.96%4.46M
1,232.79%51.58M
105.91%7.31M
--20.34M
--7.55M
Cost of revenue
2.62M
2.9M
216K
0
0
0
Gross profit
-110.70%-477K
-103.76%-1.94M
-86.19%1.01M
4.46M
51.58M
7.31M
Operating expense
-22.39%69.14M
-17.00%69.48M
-20.42%76.03M
-4.63%344.09M
-24.95%75.76M
-1.22%89.08M
-4.74%83.71M
16.79%95.53M
16.74%360.8M
23.57%100.95M
Selling and administrative expenses
-35.28%12.25M
-29.12%13.34M
-32.57%13.87M
-9.20%71.55M
-39.29%13.25M
-4.66%18.92M
-3.01%18.81M
15.97%20.57M
22.36%78.8M
35.15%21.82M
-General and administrative expense
-35.28%12.25M
-29.12%13.34M
-32.57%13.87M
-9.20%71.55M
-39.29%13.25M
-4.66%18.92M
-3.01%18.81M
15.97%20.57M
22.36%78.8M
35.15%21.82M
Research and development costs
-18.91%56.89M
-13.49%56.14M
-17.08%62.16M
-3.36%272.53M
-21.00%62.52M
-0.25%70.16M
-5.22%64.9M
17.02%74.96M
15.27%282M
20.72%79.13M
Operating profit
17.74%-69.61M
-122.25%-71.41M
14.96%-75.02M
17.61%-280.51M
19.13%-75.54M
0.22%-84.62M
61.75%-32.13M
-12.75%-88.22M
-10.16%-340.46M
-14.33%-93.4M
Net non-operating interest income expense
-120.82%-177K
-44.87%317K
108.04%466K
441.14%1.99M
302.38%338K
474.32%850K
155.56%575K
348.89%224K
-85.00%367K
-78.89%84K
Non-operating interest income
25.18%1.22M
140.77%1.7M
690.35%1.8M
441.14%1.99M
--82K
--973K
--704K
--228K
-85.00%367K
----
Non-operating interest expense
1,034.15%1.4M
968.22%1.38M
33,300.00%1.34M
----
----
--123K
--129K
--4K
----
----
Other net income (expense)
91.26%-27K
-100.02%-10K
-80.73%-197K
50.24M
631K
-309K
50.02M
-109K
Special income (charges)
--0
--0
----
--50.24M
--0
--0
--50.24M
----
--0
--0
-Gain on sale of business
----
--0
----
----
----
----
--50.24M
----
----
----
-Gain on sale of property,plant,equipment
--0
----
----
--50.24M
--0
--0
----
----
--0
--0
Other non- operating income (expenses)
91.26%-27K
95.33%-10K
-80.73%-197K
----
----
---309K
---214K
---109K
----
----
Income before tax
16.97%-69.82M
-485.07%-71.11M
15.16%-74.75M
32.87%-228.29M
20.09%-74.57M
0.69%-84.08M
122.04%18.47M
-12.47%-88.11M
-10.92%-340.1M
-14.78%-93.32M
Income tax
-290.00%-19K
1K
22K
-73.91%12K
-93.33%2K
10K
0
0
206.67%46K
275.00%30K
Net income
17.00%-69.8M
-485.08%-71.11M
15.13%-74.77M
32.88%-228.3M
20.11%-74.57M
0.68%-84.09M
122.04%18.47M
-12.47%-88.11M
-10.93%-340.14M
-14.81%-93.35M
Net income continuous Operations
17.00%-69.8M
-485.08%-71.11M
15.13%-74.77M
32.88%-228.3M
20.11%-74.57M
0.68%-84.09M
122.04%18.47M
-12.47%-88.11M
-10.93%-340.14M
-14.81%-93.35M
Minority interest income
Net income attributable to the parent company
17.00%-69.8M
-485.08%-71.11M
15.13%-74.77M
32.88%-228.3M
20.11%-74.57M
0.68%-84.09M
122.04%18.47M
-12.47%-88.11M
-10.93%-340.14M
-14.81%-93.35M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
17.00%-69.8M
-485.08%-71.11M
15.13%-74.77M
32.88%-228.3M
20.11%-74.57M
0.68%-84.09M
122.04%18.47M
-12.47%-88.11M
-10.93%-340.14M
-14.81%-93.35M
Basic earnings per share
19.51%-0.66
-477.78%-0.68
17.24%-0.72
38.29%-2.24
25.00%-0.72
8.89%-0.82
119.78%0.18
-1.16%-0.87
12.53%-3.63
-1.05%-0.96
Diluted earnings per share
19.51%-0.66
-477.78%-0.68
17.24%-0.72
38.29%-2.24
25.00%-0.72
8.89%-0.82
119.78%0.18
-1.16%-0.87
12.53%-3.63
-1.05%-0.96
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021
Total revenue -52.05%2.14M-98.14%957K-83.24%1.23M212.55%63.57M-97.07%221K-16.96%4.46M1,232.79%51.58M105.91%7.31M20.34M7.55M
Operating revenue -52.05%2.14M-98.14%957K-83.24%1.23M212.55%63.57M-97.07%221K-16.96%4.46M1,232.79%51.58M105.91%7.31M--20.34M--7.55M
Cost of revenue 2.62M2.9M216K000
Gross profit -110.70%-477K-103.76%-1.94M-86.19%1.01M4.46M51.58M7.31M
Operating expense -22.39%69.14M-17.00%69.48M-20.42%76.03M-4.63%344.09M-24.95%75.76M-1.22%89.08M-4.74%83.71M16.79%95.53M16.74%360.8M23.57%100.95M
Selling and administrative expenses -35.28%12.25M-29.12%13.34M-32.57%13.87M-9.20%71.55M-39.29%13.25M-4.66%18.92M-3.01%18.81M15.97%20.57M22.36%78.8M35.15%21.82M
-General and administrative expense -35.28%12.25M-29.12%13.34M-32.57%13.87M-9.20%71.55M-39.29%13.25M-4.66%18.92M-3.01%18.81M15.97%20.57M22.36%78.8M35.15%21.82M
Research and development costs -18.91%56.89M-13.49%56.14M-17.08%62.16M-3.36%272.53M-21.00%62.52M-0.25%70.16M-5.22%64.9M17.02%74.96M15.27%282M20.72%79.13M
Operating profit 17.74%-69.61M-122.25%-71.41M14.96%-75.02M17.61%-280.51M19.13%-75.54M0.22%-84.62M61.75%-32.13M-12.75%-88.22M-10.16%-340.46M-14.33%-93.4M
Net non-operating interest income expense -120.82%-177K-44.87%317K108.04%466K441.14%1.99M302.38%338K474.32%850K155.56%575K348.89%224K-85.00%367K-78.89%84K
Non-operating interest income 25.18%1.22M140.77%1.7M690.35%1.8M441.14%1.99M--82K--973K--704K--228K-85.00%367K----
Non-operating interest expense 1,034.15%1.4M968.22%1.38M33,300.00%1.34M----------123K--129K--4K--------
Other net income (expense) 91.26%-27K-100.02%-10K-80.73%-197K50.24M631K-309K50.02M-109K
Special income (charges) --0--0------50.24M--0--0--50.24M------0--0
-Gain on sale of business ------0------------------50.24M------------
-Gain on sale of property,plant,equipment --0----------50.24M--0--0----------0--0
Other non- operating income (expenses) 91.26%-27K95.33%-10K-80.73%-197K-----------309K---214K---109K--------
Income before tax 16.97%-69.82M-485.07%-71.11M15.16%-74.75M32.87%-228.29M20.09%-74.57M0.69%-84.08M122.04%18.47M-12.47%-88.11M-10.92%-340.1M-14.78%-93.32M
Income tax -290.00%-19K1K22K-73.91%12K-93.33%2K10K00206.67%46K275.00%30K
Net income 17.00%-69.8M-485.08%-71.11M15.13%-74.77M32.88%-228.3M20.11%-74.57M0.68%-84.09M122.04%18.47M-12.47%-88.11M-10.93%-340.14M-14.81%-93.35M
Net income continuous Operations 17.00%-69.8M-485.08%-71.11M15.13%-74.77M32.88%-228.3M20.11%-74.57M0.68%-84.09M122.04%18.47M-12.47%-88.11M-10.93%-340.14M-14.81%-93.35M
Minority interest income
Net income attributable to the parent company 17.00%-69.8M-485.08%-71.11M15.13%-74.77M32.88%-228.3M20.11%-74.57M0.68%-84.09M122.04%18.47M-12.47%-88.11M-10.93%-340.14M-14.81%-93.35M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 17.00%-69.8M-485.08%-71.11M15.13%-74.77M32.88%-228.3M20.11%-74.57M0.68%-84.09M122.04%18.47M-12.47%-88.11M-10.93%-340.14M-14.81%-93.35M
Basic earnings per share 19.51%-0.66-477.78%-0.6817.24%-0.7238.29%-2.2425.00%-0.728.89%-0.82119.78%0.18-1.16%-0.8712.53%-3.63-1.05%-0.96
Diluted earnings per share 19.51%-0.66-477.78%-0.6817.24%-0.7238.29%-2.2425.00%-0.728.89%-0.82119.78%0.18-1.16%-0.8712.53%-3.63-1.05%-0.96
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg